Stock vs Stock Comparison

MetLife, Inc. vs JPMorgan Chase & Co.

JPM wins the Tale of the Tape 5–3.

MET$80.96
JPM$300.85

🏆 Tale of the Tape

35
METJPM
4.5%Profitability (Net Margin)31.4%
16.0xValuation (P/E)14.3x
0.6%Efficiency (ROIC)
4/9Health (Piotroski F)3/9
0.3Safety (Altman Z)0.3
7.9%Growth (Rev YoY)7.3%
0.05Risk (Sharpe 1Y)1.29
24.77xBalance Sheet (D/E)11.21x

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.575
252-Day Correlation
0.565
126-Day Correlation

Moderately correlated — some diversification benefit from holding both.

Fundamentals

MetricMETJPM
Market Cap$53.2B$802.0B
P/E Ratio16.0x14.3x
Forward P/E7.5x12.7x
P/B1.96x2.33x
Dividend Yield2.87%2.00%
Beta0.781.02

Quantitative Metrics

MetricMETJPM
DCF Fair Value
DCF Upside
Piotroski F4/93/9
Altman Z0.250.30
Beneish M
FCF Yield
Net Debt/EBITDA-0.5x
ROIC0.6%
WACC7.9%8.8%
ROIC – WACC-7.3pp
Gross Margin
Net Margin4.5%31.4%
Rev Growth YoY7.9%7.3%
Sharpe (1Y)0.051.29
Max Drawdown 3Y-24.4%
FCF Payout Ratio

MET Price

Loading chart...

JPM Price

Loading chart...

ETF Exposure

MET found in:

KIE2.13%
VOE0.79%
DVY0.73%
XLF0.63%
VFH0.53%
VO0.45%
VFVA0.33%
VIG0.20%
RSP0.19%
VYM0.19%
VTV0.17%
SPYV0.16%
VONV0.14%
SCHV0.13%
IWD0.13%
ESGV0.08%
QUS0.08%
IVV0.07%
SPLG0.07%
SPY0.07%
SPTM0.07%
VOO0.07%
VONE0.07%
ITOT0.07%
SCHX0.06%
VTI0.06%
SCHB0.06%
URTH0.05%
ONEO0.05%
ACWI0.05%
VT0.04%

JPM found in:

XLF11.08%
IYF10.78%
VFH9.53%
MGV3.96%
DIA3.71%
VIG3.59%
VYM3.34%
VTV3.11%
DGRO3.04%
SCHV2.76%
IWD2.63%
VONV2.46%
DGRW2.07%
SPYG1.59%
LRGF1.50%
ESGV1.50%
IVV1.50%
SPLG1.43%
ITOT1.33%
SCHX1.31%
VOO1.28%
SPY1.28%
SCHB1.23%
VONE1.22%
SPTM1.18%
VTI1.14%
DFAC1.00%
KBE0.98%
URTH0.97%
SPYV0.91%
ACWI0.88%
QUS0.85%
VT0.70%
VFMO0.23%
RSP0.19%
VFVA0.07%
VFMV0.02%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

MET vs JPM: Head-to-Head Analysis

MetLife, Inc. (MET) and JPMorgan Chase & Co. (JPM) represent two companies in the Financial Services sector. In our quantitative Tale of the Tape scoring, JPM leads 5–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

The 252-day rolling correlation between MET and JPM is 0.575, indicating moderate co-movement, with some diversification value from holding both in a portfolio context.

MET appears in 31 ETFs tracked by SecuritiesDB, while JPM appears in 37 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, MET or JPM?

Our quantitative analysis compares MET and JPM across nine fundamental dimensions. JPM wins the Tale of the Tape 5–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are MET and JPM correlated?

The 252-day correlation between MET and JPM is 0.575. They show moderate correlation — partially diversifying.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.